Founded
Address
Flagship Ventures
One Memorial Drive
7th Floor
Cambridge, MA 02142
United States
Phone
Website
Recent investment activity
KANDO id: 30843
Company type
Venture capital firmRelation
Renamed to
Funding rounds
Investment preferences
Investment activity status
Not investing
Selected investments
Displaying 26 - 50 of 89| Company | Profile | Country | Date Sort ascending | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Hypnion Inc | N/A | ||||
|
|
Everyday Solutions Inc | A software company providing student transportation information solutions to enhance safety, security and efficiency. | N/A | |||
|
|
Bind Biosciences Inc | Developer of “smart” therapeutic targeted nano-particles capable of differential delivery and controlled drug release to diseased tissue | Series B | |||
|
|
Novomer Inc | An emerging sustainable chemistry company pioneering a family of high performance, environmentally responsible polymers and chemical intermediates. | Series A | |||
|
|
BDNA Corp | Series D | ||||
|
|
Interactive Supercomputing Inc | Series B | ||||
|
Acceleron Pharma Inc | Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. | Series C Initial investment | |||
|
|
Alvine Pharmaceuticals Inc | An innovative biopharmaceutical company developing biologics to target autoimmune/ inflammatory diseases. | N/A | |||
|
|
Tetraphase Pharmaceuticals Inc | A biopharmaceutical company utilizing a synthetic chemistry technology platform to treat drug-resistant bacterial infections. | N/A | |||
|
|
Concert Pharmaceuticals Inc | A biotechnology company creating new medicines through a novel scientific approach utilizing the naturally-occurring element deuterium. | Series B | |||
|
|
Mascoma Corp | A biofuel company that develops innovative technology for the low-cost conversion of abundant biomass to renewable fuels and chemicals. | N/A Initial investment | |||
|
|
SiCortex Inc | High-performance computing company. | Series B | |||
|
|
Acceleron Pharma Inc | Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. | Series B | |||
|
|
Interactive Supercomputing Inc | Series A | ||||
|
|
Resolvyx Pharmaceuticals Inc | A biopharmaceutical company developing resolvins, a novel class of therapies to treat inflammatory diseases and their complications. | N/A | |||
|
|
VisEn Medical Inc | A fluorescence molecular imaging technology company developing fluorescence-based agents and systems for non-invasive imaging. | N/A | |||
|
|
INTIO Inc (INTegrating Interventional Oncology) | A medical device company providing a platform to support the emerging interventional oncology market. | N/A | |||
|
|
Interactive Supercomputing Corp (ISC) | A software company focused on enabling applications transparent use of cluster supercomputers, maker of the desktop parallel computing platform Star-P | N/A | |||
|
Ellacoya Networks Inc | N/A Initial investment | ||||
|
|
Acceleron Pharma Inc | Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. | N/A | |||
|
Black Duck Software Inc | Software company focused on providing strategy, products, and services for enabling enterprise scale adoption of open source software (OSS). | Series A | |||
|
|
AVEO Pharmaceuticals Inc | Biopharmaceutical company discovering, developing and commercializing cancer therapeutics. | N/A | |||
|
|
Pervasis Therapeutics Inc | A biotechnology company developing novel therapeutics to promote vascular repair. | N/A | |||
|
|
Compound Therapeutics Inc | Biotechnology company focused on protein-based drugs. | Series A | |||
|
|
Carbon Design Systems Inc | Software company in the electronic design solutions market. | N/A |